SMTL ID : 5x26.1

Crystal structure of EGFR 696-1022 L858R in complex with SKLB(3)

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.95 Å

Oligo State

monomer

Ligands

1 x 7XO: N2-[4-(4-methylpiperazin-1-yl)phenyl]-N8-phenyl-9-propan-2-yl-purine-2,8-diamine(Non-covalent)

7XO.1: 15 residues within 4Å: Chain A: L.23, V.31, A.48, K.50, E.67, M.71, T.95, Q.96, L.97, M.98, P.99, G.101, D.105, E.109, L.149 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:L.23, A:K.50, A:T.95 Hydrogen bonds: A:M.98, A:M.98 Salt bridges: A:E.109

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.2: 4 residues within 4Å: Chain A: P.182, I.183, K.184, W.185 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zhu, S.J. et al., Structural insights into drug development strategy targeting EGFR T790M/C797S. Oncotarget (2018)

Release Date

2018-02-07

Peptides

Epidermal growth factor receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Epidermal growth factor receptor

Related Entries With Identical Sequence